Clinical trial reportJournal of the American Heart AssociationPublished
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT
Regional connection
Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Lankenau Institute for Medical Research, Philadelphia VA Medical Center, with Main Line Health, Penn Medicine linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Journal of the American Heart Association
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Atrial Fibrillation; Eicosapentaenoic Acid; Treatment Outcome; Risk Factors; Stroke; Eicosapentaenoic acid; Bleeding; Prevention; Atrial fibrillation; Icosapent Ethyl
- PubMed ID
- 36802845
- PubMed Central ID
- PMC10111466
- Open access
- Yes, open
- Added to directory
- Source checked